Bartlett & Co. Wealth Management LLC Cti Biopharma Corp Transaction History

Bartlett & Co. Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 14, 2024	SELL	$4.08 - $9.1 $151,110 - $337,036	-37,037 Closed	0 $0
Q3 2022 Feb 14, 2024	BUY	$5.36 - $7.43 $198,518 - $275,184	37,037 New	37,037 $216 Million
Q2 2022 Feb 14, 2024	SELL	$3.55 - $6.27 $129,575 - $228,854	-36,500 Closed	0 $0
Q4 2021 Feb 14, 2024	BUY	$1.44 - $2.86 $52,560 - $104,390	36,500 New	36,500 $90.5 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.